0

Hikma Pharmaceuticals PLC (HIK) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 6-Jun-2017
No. of pages: 56

Hikma Pharmaceuticals Plc (HIK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hikma Pharmaceuticals Plc (Hikma) is a pharmaceutical company which undertakes the development, manufacturing and marketing of branded and non-branded generics and in-licensed products. The company specializes in the therapeutic areas of cardiovascular and diabetes, central nervous system, oncology, dermatology, genitourinary system, hormones and respiratory system, among others. It offers generics in various dosage forms including tablets, capsules, solutions and suspensions. Hikma markets its products across Europe, the US, the Middle East and North Africa region. It has manufacturing facilities in the US, Portugal, Germany, Jordan, Algeria, Sudan, Saudi Arabia, Egypt, Tunisia and Morocco. Hikma is headquartered in London, the UK.

Hikma Pharmaceuticals Plc Key Recent Developments

May 03,2017: Hikma Changes Registered Office
Mar 15,2017: Hikma delivers a solid financial performance in 2016 and makes significant strategic progress Strong growth in revenue and core operating profit in constant currency
Nov 10,2016: Hikma Pharmaceuticals: Trading Update
Sep 20,2016: Hikma Pharmaceuticals: Board Appointment and Succession
Aug 24,2016: Hikma delivers solid first half performance and reiterates full year revenue guidance of $2.0 billion to $2.1 billion

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Hikma Pharmaceuticals Plc - Key Facts 5
Hikma Pharmaceuticals Plc - Key Employees 6
Hikma Pharmaceuticals Plc - Key Employee Biographies 7
Hikma Pharmaceuticals Plc - Major Products and Services 8
Hikma Pharmaceuticals Plc - History 9
Hikma Pharmaceuticals Plc - Company Statement 13
Hikma Pharmaceuticals Plc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Section 2 - Company Analysis 17
Hikma Pharmaceuticals Plc - Business Description 17
Hikma Pharmaceuticals Plc - Corporate Strategy 18
Hikma Pharmaceuticals Plc - SWOT Analysis 19
SWOT Analysis - Overview 19
Hikma Pharmaceuticals Plc - Strengths 19
Hikma Pharmaceuticals Plc - Weaknesses 20
Hikma Pharmaceuticals Plc - Opportunities 21
Hikma Pharmaceuticals Plc - Threats 22
Hikma Pharmaceuticals Plc - Key Competitors 23
Section 3 - Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 - Company's Lifesciences Financial Deals and Alliances 31
Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32
Hikma Pharmaceuticals Plc, Recent Deals Summary 33
Section 5 - Company's Recent Developments 34
May 03, 2017: Hikma Changes Registered Office 34
Mar 15, 2017: Hikma delivers a solid financial performance in 2016 and makes significant strategic progress Strong growth in revenue and core operating profit in constant currency 35
Nov 10, 2016: Hikma Pharmaceuticals: Trading Update 36
Sep 20, 2016: Hikma Pharmaceuticals: Board Appointment and Succession 37
Aug 24, 2016: Hikma delivers solid first half performance and reiterates full year revenue guidance of $2.0 billion to $2.1 billion 39
May 24, 2016: Michael Raya, CEO of West-Ward Pharmaceuticals, Hikma's wholly-owned subsidiary in the US, joins GPhA Board 45
Mar 16, 2016: Hikma Pharmaceuticals Preliminary Results 46
Feb 22, 2016: Hikma Appoints John Castellani to Board of Directors 50
Section 6 - Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Hikma Pharmaceuticals Plc, Key Facts 6
Hikma Pharmaceuticals Plc, Key Employees 7
Hikma Pharmaceuticals Plc, Key Employee Biographies 8
Hikma Pharmaceuticals Plc, Major Products and Services 9
Hikma Pharmaceuticals Plc, History 10
Hikma Pharmaceuticals Plc, Subsidiaries 16
Hikma Pharmaceuticals Plc, Joint Venture 17
Hikma Pharmaceuticals Plc, Key Competitors 24
Hikma Pharmaceuticals Plc, Ratios based on current share price 25
Hikma Pharmaceuticals Plc, Annual Ratios 26
Hikma Pharmaceuticals Plc, Annual Ratios (Cont...1) 27
Hikma Pharmaceuticals Plc, Annual Ratios (Cont...2) 28
Hikma Pharmaceuticals Plc, Interim Ratios 30
Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32
Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 33
Hikma Pharmaceuticals Plc, Recent Deals Summary 34
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55

List of Figures
Hikma Pharmaceuticals Plc, Performance Chart (2012 - 2016) 29
Hikma Pharmaceuticals Plc, Ratio Charts 31
Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32
Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 33

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2020 RnR Company Profiles. All rights reserved.